Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
What the TRIUMPH 4 Phase 3 Data Actually Shows The phase 2 data that first made headlines reported approximately 24 percent body weight loss at 48 weeks
Semaglutide functions as a GLP-1 receptor agonist, which means it mimics the action of the glucagon-like peptide-1 hormone in the body
The trial was not blinded since original drug packs and information for both semaglutide and tirzepatide were used
Serious adverse events were fewer in the semaglutide group (33.4% vs 36.4%), including cardiac disorders specifically (11.5% vs 13.5%)
US$ 24.39
US$ 22.73
US$ 20.23
